# US 2021/0082541 A1 · Measuring attributes of a viral gene delivery vehicle sample via separation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0082541 A1
- Document ID: US20210082541A1
- Status: Published application
- Kind: A1
- Application number: 16/991,016
- Filed: 2020-08-11
- Published: 2021-03-18
- Earliest claimed: 2019-08-31
- Assignees: Wyatt Technology Corporation
- Applicants: Wyatt Technology Corporation
- Inventors: Michelle H. Chen; Anatolii Purchel
- Web page: https://patentgrep.com/patent/US20210082541A1

## CPC

- G01N 15/0612: {Optical scan of the deposits (G01N15/0625 takes precedence)}
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- G01N 15/06: Investigating concentration of particle suspensions (by weighing G01N5/00; investigating sedimentation of particle suspensions G01N15/04; investigating individual particles G01N15/10)
- G01N 15/0618: {of the filter type (G01N15/0643 takes precedence)}
- G01N 15/1429: Signal processing
- G01N 30/0005: {Field flow fractionation}
- G01N 30/78: using more than one detector
- G01N 30/8675: {Evaluation, i.e. decoding of the signal into analytical information (for analysis of specific compounds see also G01N30/88 and subgroups of G01N33/00; chemical libraries per se C40B)}
- G01N 15/075: by optical means
- G01N 21/33: using ultraviolet light (G01N21/39 takes precedence)
- G01N 21/4133: {Refractometers, e.g. differential}
- G01N 21/51: inside a container, e.g. in an ampoule (G01N21/53 takes precedence)
- G01N 2015/0053: {in liquids, e.g. trouble}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The present disclosure describes an apparatus, method, and system of measuring attributes of a viral gene delivery vehicle sample via separation. In an embodiment, the method, system, and computer program product include executing a set of logical operations analyzing a viral gene delivery vehicle sample on a set of analytical instruments, where the set includes at least one separation instrument, at least one static light scattering instrument, and at least two concentration detectors, resulting in a capsid protein mass of the sample, mA, a modifier mass of the sample, mB, and a modifier molar mass of the sample, MB, receiving a capsid protein molar mass of the sample, MA, from a capsid protein molar mass data source, receiving an injection volume of the sample, v, from an injection volume data source, and executing a set of logical operations calculating a total VGDV particle concentration of the sample, CA.

## Claims

### Claim 1

A computer implemented method comprising:
executing, by a computer system, a set of logical operations analyzing a viral gene delivery vehicle (VGDV) sample on a set of analytical instruments,
wherein the set comprises at least one separation instrument, at least one static light scattering instrument, and at least two concentration detectors,
resulting in a capsid protein mass of the sample, mA, a modifier mass of the sample, mB, and a modifier molar mass of the sample, MB;
receiving a capsid protein molar mass of the sample, MA, from a capsid protein molar mass data source;
receiving an injection volume of the sample, v, from an injection volume data source; and
executing, by the computer system, a set of logical operations calculating a total VGDV particle concentration of the sample, CA, via
CA=(mA×N)/(MA×v),
wherein N is Avogrado's number.

### Claim 2 (depends on 1)

The method of claim 1 further comprising:
executing, by the computer system, a set of logical operations analyzing the sample on the set, resulting in the capsid protein molar mass of the sample, MA; and
storing the capsid protein molar mass of the sample, MA, in the capsid protein molar mass data source.

### Claim 3 (depends on 1)

The method of claim 1 wherein the analyzing comprises analyzing the sample on the set via an analysis technique,
wherein the analysis technique is one of viral vector analysis, protein conjugate analysis, and copolymer composition analysis.

### Claim 4 (depends on 1)

The method of claim 1 wherein the at least one separation instrument comprises at least one of a size exclusion chromatography unit, a field flow fractionation unit, and an ion-exchange chromatography unit.

### Claim 5 (depends on 1)

The method of claim 1 wherein the at least one static light scattering instrument comprises a multi-angle light scattering instrument.

### Claim 6 (depends on 1)

The method of claim 1 wherein the at least two concentration detectors comprise a first ultra-violet absorbance detector at a first wavelength, λ1, and a second ultra-violet absorbance detector at a second wavelength, λ2.

### Claim 7 (depends on 6)

The method of claim 6
wherein the first wavelength, λ1, is 260 nm, and
wherein the second wavelength, λ2, is 280 nm.

### Claim 8 (depends on 1)

The method of claim 1 wherein the at least two concentration detectors comprise an ultra-violet absorbance detector at a wavelength, λ, and a differential refractive index detector.

### Claim 9 (depends on 8)

The method of claim 8 wherein the wavelength, λ, is one of 260 nm and 280 nm.

### Claim 10 (depends on 1)

The method of claim 1 wherein the at least two concentration detectors comprise an ultra-violet absorbance detector at a wavelength, λ, and a fluorescence detector.

### Claim 11 (depends on 10)

The method of claim 10 wherein the wavelength, λ, is one of 260 nm and 280 nm.

### Claim 12 (depends on 1)

The method of claim 1 wherein the at least two concentration detectors comprise a differential refractive index detector and a fluorescence detector.

### Claim 13 (depends on 1)

The method of claim 1 wherein the modifier mass of the sample, mB, is a nucleic acid mass of the sample.

### Claim 14 (depends on 1)

The method of claim 1 wherein the modifier molar mass of the sample, MB, is a nucleic acid molar mass of the sample.

### Claim 15 (depends on 1)

The method of claim 1 further comprising:
receiving, by the computer system, a molar mass of a full modifier inside a full VGDV sample, MFull, from a full modifier molar mass data source;
executing, by the computer system, a set of logical operations calculating a full VGDV concentration of the full VGDV sample, CFull, via
CFull=(mB×N)/(MFull×v); and
executing, by the computer system, a set of logical operations calculating an empty VGDV concentration of the full VGDV sample, CEmpty, via
CEmpty=CA−CFull.

### Claim 16 (depends on 15)

The method of claim 15 further comprising
executing, by the computer system, a set of logical operations analyzing the full VGDV sample on the set,
resulting in the molar mass of the full modifier inside the full VGDV sample, MFull; and
storing the molar mass of the full modifier inside the full VGDV sample, MFull, in the full modifier molar mass data source.

### Claim 17 (depends on 15)

The method of claim 15 wherein the modifier is a nucleic acid.

### Claim 18 (depends on 1)

The method of claim 1 further comprising:
executing, by the computer system, a set of logical operations analyzing an entire VGDV signal region of the sample on the set and analyzing an aggregate peak region of the sample on the set,
resulting in a VGDV entire peak protein mass of the sample, mA, ent, corresponding to the entire VGDV signal region of the sample, a VGDV entire peak modifier mass of the sample, mB, ent, corresponding to the entire VGDV signal region of the sample, a VGDV entire peak protein molar mass of the sample, MA, ent, corresponding to the entire VGDV signal region of the sample, a VGDV entire peak modifier molar mass of the sample, MB, ent, corresponding to the entire VGDV signal region of the sample, a VGDV aggregate peak protein mass of the sample, mA, agg, corresponding to the aggregate peak region of the sample, a VGDV aggregate peak modifier mass of the sample, mB, agg, corresponding to the aggregate peak region of the sample, a VGDV aggregate peak protein molar mass of the sample, MA, agg, corresponding to the aggregate peak region of the sample, a VGDV aggregate peak modifier molar mass of the sample, MB, agg, corresponding to the aggregate peak region of the sample; and
executing, by the computer system, a set of logical operations calculating a total VGDV entire peak particle concentration of the sample, CA, ent, corresponding to the entire VGDV signal region of the sample, via
CA, ent=(mA, ent×N)/(MA, ent×v); and
executing, by the computer system, a set of logical operations calculating a total VGDV aggregate peak particle concentration of the sample, CA, agg, corresponding to the aggregate peak region of the sample, via
CA, agg (mA, agg×N)/(MA, agg×v).

### Claim 19 (depends on 18)

The method of claim 18 further comprising:
executing, by the computer system, a set of logical operations analyzing an entire VGDV signal region of a full viral gene delivery vehicle sample on the set and analyzing an aggregate peak region of the full sample on the set,
resulting in a VGDV entire peak molar mass of a full modifier inside the full sample, MFull, ent, corresponding to the entire VGDV signal region of the full sample, and a VGDV aggregate peak molar mass of the full modifier inside the full sample, MFull, agg, corresponding to the aggregate peak region of the full sample;
executing, by the computer system, a set of logical operations calculating a VGDV entire peak full VGDV concentration of the full sample, CFull, ent, corresponding to the entire VGDV signal region of the VGDV sample, via
CFull, ent=(mB, ent×N)/(MFull, ent×v);
executing, by the computer system, a set of logical operations calculating a VGDV aggregate peak full VGDV concentration of the full sample, CFull, agg, corresponding to the aggregate peak region of the full sample, via
CFull, agg=(mB, agg×N)/(MFull, agg×v);
executing, by the computer system, a set of logical operations calculating a VGDV entire peak empty VGDV concentration of the full sample, CEmpty, ent, corresponding to the entire VGDV signal region of the full sample, via
CEmpty, ent=CA, ent−CFull, ent; and
executing, by the computer system, a set of logical operations calculating a VGDV aggregate peak empty VGDV concentration of the full sample, CEmpty, agg, corresponding to the aggregate peak region of the full sample, via
CEmpty, agg=CA, agg−CFull, agg.

### Claim 20

A computer implemented method comprising:
executing, by a computer system, a set of logical operations analyzing a viral gene delivery vehicle (VGDV) sample on a set of analytical instruments,
wherein the set comprises at least one separation instrument, at least one static light scattering instrument, and at least one concentration detector,
resulting in a modifier mass of the sample, mB, a modifier molar mass of the sample, MB, and at least one UV extinction coefficient of the sample;
executing, by the computer system, a set of logical operations calculating a capsid protein mass of the sample, mA, and a capsid protein molar mass of the sample, MA, with respect to at least one refractive-index increment value from the at least one concentration detector;
receiving an injection volume of the sample, v, from an injection volume data source; and
executing, by the computer system, a set of logical operations calculating a total VGDV particle concentration of the sample, CA, via
CA=(mA×N)/(MA×v),
wherein N is Avogrado's number.

### Claim 21

A computer implemented method comprising: (UV-UV)
executing, by a computer system, a set of logical operations analyzing a viral gene delivery vehicle (VGDV) sample on a set of analytical instruments,
wherein the set comprises at least one separation instrument, at least one static light scattering instrument, and at least two concentration detectors;
executing, by the computer system, a set of logical operations calculating a mass fraction of a protein in the sample, XA, with respect to an ultra-violet absorbance value, Aλ1, collected from the sample at a first wavelength, λ1, an ultra-violet absorbance value, Aλ2, collected from the sample at a second wavelength, λ2, an extinction coefficient of the protein, εAλ1, at the first wavelength, λ1, an extinction coefficient of the protein, εAλ2, at the second wavelength, λ2, an extinction coefficient of a modifier in the sample, εBλ2, at the first wavelength, λ1, and an extinction coefficient of the modifier in the sample, εBλ2, at the second wavelength, λ2;
executing, by the computer system, a set of logical operations calculating an extinction coefficient of the sample at the first wavelength, εVGDVλ1, with respect to the mass fraction of the protein in the sample, XA, the extinction coefficient of the protein at the first wavelength, εAλ1, and the extinction coefficient of the modifier in the sample at the first wavelength, εBλ1;
executing, by the computer system, a set of logical operations calculating an extinction coefficient of the sample at the second wavelength, εVGDVλ2, with respect to the mass fraction of the protein in the sample, XA, the extinction coefficient of the protein at the second wavelength, εAλ2, and the extinction coefficient of the modifier in the sample at the second wavelength, εBλ2;
executing, by the computer system, a set of logical operations calculating a refractive index increment of the sample, (dn/dc)VGDV, with respect to the mass fraction of the protein in the sample, XA, a refractive index coefficient of the protein, (dn/dc)A, and a refractive index coefficient of the modifier in the sample, (dn/dc)B;
executing, by the computer system, a set of logical operations calculating a total mass of the protein, mA, and a total mass of the modifier, mB, with respect to an ultra-violet absorbance value, Aλ, collected from the sample at a wavelength, λ, the mass fraction of the protein in the sample, XA, an extinction coefficient of the protein, εAλ, at the wavelength, λ, an extinction coefficient of a modifier in the sample, εBλ, at the wavelength, λ, where the wavelength, λ, is one of the first wavelength, λ1, and the second wavelength, λ2; and
executing, by the computer system, a set of logical operations calculating a total VGDV particle concentration of the sample, CA, via
CA=(mA×N)/(MA×v),
wherein N is Avogrado's number,
wherein MA is a capsid protein molar mass of the sample from a capsid protein molar mass data source.

### Claim 22 (depends on 21)

The method of claim 21
wherein the calculating the mass fraction of the protein in the sample, XA, comprises calculating the mass fraction of the protein in the sample, XA, via
XA=((Aλ1×εBλ2)−(Aλ2×εBλ1))/((Aλ2×εAλ1)−(Aλ2×εBλ1)−(Aλ1×εAλ2)+(Aλ1×εBλ2)),
wherein the calculating the extinction coefficient of the sample at the first wavelength, εVGDVλ1, comprises calculating the extinction coefficient of the sample at the first wavelength, εVGDVλ1, via
εVGDVλ1=(XA×εAλ1)+((1−XA)×εBλ1),
wherein the calculating the extinction coefficient of the sample at the second wavelength, εVGDVλ2, comprises calculating the extinction coefficient of the sample at the second wavelength, εVGDVλ2, via
εVGDVλ2=(XA×√Aλ2)+((1−XA)×εBλ2),
wherein the calculating the refractive index increment of the sample, (dn/dc)VGDV, comprises calculating the refractive index increment of the sample, (dn/dc)VGDV, via
(dn/dc)VGDV=(XA×(dn/dc)A)+((1−XA)×(dn/dc)B),
wherein the calculating the total mass of the protein, mA, comprises calculating the total mass of the protein, mA, via
mA=(Aλ×XA)/((XA×εAλ))+((1−XA)×εBλ)),
wherein the calculating the total mass of the modifier, mB, comprises calculating the total mass of the modifier, mB, via
mB=(Aλ×(1−XA))/((XA×εAλ)+((1−XA)×εBλ)).

### Claim 23 (depends on 21)

The method of claim 21
wherein the first wavelength, λ1, is 260 nm, and wherein the second wavelength, λ2, is 280 nm.

### Claim 24 (depends on 21)

The method of claim 21 wherein the modifier is a nucleic acid.

### Claim 25

A computer implemented method comprising: (UV-dRI)
executing, by a computer system, a set of logical operations analyzing a viral gene delivery vehicle (VGDV) sample on a set of analytical instruments,
wherein the set comprises at least one separation instrument, at least one static light scattering instrument, and at least two concentration detectors;
executing, by the computer system, a set of logical operations calculating a mass fraction of a protein in the sample, XA, with respect to an ultra-violet absorbance value, Aλ, collected from the sample at a wavelength, λ, a refractive index coefficient of a modifier in the sample, (dn/dc)B, a differential refractive index of a solution containing the sample, dRI, an extinction coefficient of the modifier, εBλ, at the wavelength, λ, an extinction coefficient of the protein, εAλ, at the wavelength, λ, a refractive index coefficient of the protein, (dn/dc)A;
executing, by the computer system, a set of logical operations calculating an extinction coefficient of the sample at the wavelength, εVGDVλ, with respect to the mass fraction of the protein in the sample, XA, the extinction coefficient of the protein at the wavelength, εAλ, and the extinction coefficient of the modifier in the sample at the wavelength, εBλ;
executing, by the computer system, a set of logical operations calculating a refractive index increment of the sample, (dn/dc)VGDV, with respect to the mass fraction of the protein in the sample, XA, the refractive index coefficient of the protein, (dn/dc)A, and the refractive index coefficient of the modifier in the sample, (dn/dc)B;
executing, by the computer system, a set of logical operations calculating a total mass of the protein, mA, and a total mass of the modifier, mB, with respect to the differential refractive index of the solution containing the sample, dRI, the mass fraction of the protein in the sample, XA, the refractive index coefficient of the protein, (dn/dc)A, and the refractive index coefficient of the modifier in the sample, (dn/dc)B; and
executing, by the computer system, a set of logical operations calculating a total VGDV particle concentration of the sample, CA, via
CA=(mA×N)/(MA×v),
wherein N is Avogrado's number,
wherein MA is a capsid protein molar mass of the sample from a capsid protein molar mass data source.

### Claim 26 (depends on 25)

The method of claim 25
wherein the calculating the mass fraction of the protein in the sample, XA, comprises calculating the mass fraction of the protein in the sample, XA, via
XA=((Aλ×(dn/dc)B)−(dRI×εBλ))/((dRI×εAλ)−(dRI×εBλ)−(Aλ×(dn/dc)A)+(Aλ×(dn/dc)B)),
wherein the calculating the extinction coefficient of the sample at the wavelength, εVGDVλ, comprises calculating the extinction coefficient of the sample at the wavelength, εVGDVλ, via
εVGDVλ=(XA×εAλ)+((1−XA)×εBλ),
wherein the calculating the refractive index increment of the sample, (dn/dc)VGDV, comprises calculating the refractive index increment of the sample, (dn/dc)VGDV, via
(dn/dc)VGDV=(XA×(dn/dc)A)+((1−XA)×(dn/dc)B),
wherein the calculating the total mass of the protein, mA, comprises calculating the total mass of the protein, mA, via
mA=(dRI×XA)/((XA×(dn/dc)A)+((1−XA)×(dn/dc)B)),
wherein the calculating the total mass of the modifier, mB, comprises calculating the total mass of the modifier, mB, via
mB=(dRI×(1−XA))/((XA×(dn/dc)A)+((1−XA)×(dn/dc)B)).

### Claim 27 (depends on 25)

The method of claim 25 wherein the wavelength, λ, is one of 260 nm and 280 nm.

### Claim 28 (depends on 25)

The method of claim 25 wherein the modifier is a nucleic acid.
